Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04288752 · ClinicalTrials.gov registry record · NA

Efficacy of VR101 as a Personal Lubricant

A NA study, sponsored by J3 Bioscience.

Completed
Registry status
NA
Development phase
176
Enrollment target

NCT04288752 is a NA study that has completed, run by J3 Bioscience. The registered enrollment target is 176 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04288752, a NA study, has completed, sponsored by J3 Bioscience.

COMPLETED
Registry status
NA
Development phase
176 participants
Enrollment target

Study Summary

This Clinical Investigation (CI03) is designed to validate the efficacy of the VR101 lubricating Intravaginal Ring (IVR) as a personal lubricant device. In the proposed clinical investigation, participants will be randomized into two groups for the study, VR101 Active Ring and Inactive Ring. Participants will use VR101 active rings or inactive rings for 28 days in a randomized, double-blind, parallel group design. The study also includes an optional two-week open-label extension with active rings, and a one-week follow-up.

Interventions

  • DEVICE VR101 Lubricating Intravaginal Ring
  • DEVICE Sham Ring

Trial Details

FieldValue
Enrollment Target 176 participants
Start Date 2020-02-26
Est. Completion 2020-05-26
Phase NA

Sponsor

J3 Bioscience

3 total trials

What the Registry Record Tells You About NCT04288752

The ClinicalTrials.gov registry entry for NCT04288752 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 176 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is J3 Bioscience, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which VR101 Lubricating Intravaginal Ring is the first listed.

NCT04288752 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04288752 about?

NCT04288752 is a clinical study titled "Efficacy of VR101 as a Personal Lubricant". This Clinical Investigation (CI03) is designed to validate the efficacy of the VR101 lubricating Intravaginal Ring (IVR) as a personal lubricant device. In the proposed clinical investigation, participants will be randomized into two groups for the study, VR101 Active Ring and Inactive Ring. Partici...

What is the current status of trial NCT04288752?

This trial is currently completed. It is a NA study. The enrollment target is 176 participants. The study started on 2020-02-26. Estimated completion is 2020-05-26.

What interventions are being tested in trial NCT04288752?

The interventions under investigation include: VR101 Lubricating Intravaginal Ring (DEVICE), Sham Ring (DEVICE).

Who is sponsoring clinical trial NCT04288752?

This trial is sponsored by J3 Bioscience, which has 3 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.